US EditionAll the Steps Syngenta Is Taking on a Global Level to Step Strong in the Growing Biological Market
Summary by Bichos De Campo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In May of this year, Syngenta opened in Orangeburg, South Carolina, a new plant of 22,000 square meters dedicated exclusively to the production of agricultural biostimulants. It is a state-of-the-art facility that has the capacity to manufacture up to 16,000 tons per year and that, according to the company itself, will be key to doubling its global volume of biologicals by 2028. This new complex on American soil joins the network of plants that …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
